Week 3 2025 Mon 4/7-Sun 4/13 | |||||||||
| Team | Coach Rating | M | T | W | T | F | S | S | Total |
|---|---|---|---|---|---|---|---|---|---|
| (9-10) | 5 | 47 | 27 | 26 | 21 | 8 | 10 | 143.8 | |
| (7-12) | 14 | 32 | 25 | 4 | 22 | 28 | 30 | 154.76 | |
| Final Non-Division Game | |||||||||
| Name | Opp | Stats | Day | Total | Pos | Total | Day | Stats | Opp | Name | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
C/DH LAA | — | 3.9 | C | 7.1 | — | C PHI | ||||||
1B ATL | — | 7 | 1B | 16.4 | -0.3 | 0-4 AVG | 1B/3B/DH HOU | |||||
2B/SS CHC | — | 4.1 | 2B | 15.6 | — | 2B ATL | ||||||
SS CHC | 0-3 AVG | 0 | 7.8 | SS | 6.2 | 0.3 | 1-4 AVG | SS SF | ||||
2B/SS/3B PIT | 2-4 AVG 2 RBI | 4.5 | 5.9 | 3B | 6.7 | — | DTDN. Arenado 3B STL | |||||
LF/DH MIL | — | 11.5 | OF | 10.7 | 3.8 | 1-5 AVG 3 RBI | LF CHC | |||||
LF/CF/DH DET | 0-4 AVG | -1.3 | -2.6 | OF | 10.6 | 2.2 | 2-3 AVG 1 RBI | RF NYM | ||||
LF/RF/DH DET | 0.5 | 7.8 | OF | 9.1 | — | CF ATL | ||||||
SS COL | — | 4.7 | UTIL | 9.5 | 6 | 3-4 AVG 2 RBI | DH/SP LAD | |||||
SP LAA | — | 14.95 | SP | 11.17 | — | SP SF | ||||||
SP HOU | — | 12.77 | SP | 10.62 | — | SP TB | ||||||
RP LAA | — | 7.75 | RP | 6.92 | — | RP TB | ||||||
RP KC | 1 IP | 1.67 | 4.17 | RP | 1.5 | 1.5 | 1 IP | RP BAL | ||||
P CIN | — | 8.62 | P | — | — | 15DC. Schmidt SP NYY | ||||||
SP CIN | — | 1.17 | P | 13.52 | — | SP CIN | ||||||
SP ATH | — | 11.08 | P | — | — | SP DET | ||||||
| Total | 5.37 | 143.8 | 154.76 | 13.5 | Total | |||||||
| Optimum | 5.37 | 117.07 | 158.73 | 19.5 | Optimum | |||||||
Benched | ||||||||||||
10DR. Lewis 3B/DH MIN | — | — | BN | 19.4 | 4.8 | 2-3 AVG 1 RBI | 1B CHC | |||||
60DC. Sale SP ATL | — | 9.75 | BN | — | — | 10DZ. Gelof 2B ATH | ||||||
SP CHC | — | 8.92 | BN | 10.4 | 0.9 | 1-4 AVG | LF/CF ATH | |||||
SP DET | — | 10.85 | BN | — | — | LF/CF TEX | ||||||
SP SD | — | 5.27 | BN | 3.5 | -0.2 | 0-4 AVG 1 RBI | RF STL | |||||
| Total | 0 | 2.1 | 44.4 | 5.5 | Total | |||||||
Injured Reserve | ||||||||||||
10DF. Freeman 1B LAD | — | 1.2 | IL | |||||||||
SP MIL | — | — | IL | |||||||||
SP TB | — | — | IL | |||||||||